Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Urology

Retrieve available abstracts of 144 articles:
HTML format
Text format



Single Articles


    January 2018
  1. CANCIAN M, Renzulli JF 2nd
    Non Metastatic Castration Resistant Prostate Cancer: a Modern Perspective.
    Urology. 2018 Jan 18. pii: S0090-4295(18)30044.
    PubMed     Text format     Abstract available


  2. WALLIS CJD, Satkunasivam R, Herschorn S, Law C, et al
    Association between Primary Local Treatment and Non-Prostate Cancer Mortality in Men with Non-Metastatic Prostate Cancer.
    Urology. 2018 Jan 2. pii: S0090-4295(17)31330.
    PubMed     Text format     Abstract available


    December 2017
  3. TANG V, Campbell P, Pattison DA
    Lymphangitic Carcinomatosis From Prostate Cancer Identified with Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging.
    Urology. 2017 Dec 29. pii: S0090-4295(17)31327.
    PubMed     Text format     Abstract available


  4. WERNEBURG GT, Kongnyuy M, Halpern DM, Salcedo JM, et al
    Effects of Focal Versus Total Cryotherapy and Minimum Tumor Temperature on Patient-Reported Quality of Life as Compared to Active Surveillance in Prostate Cancer Patients.
    Urology. 2017 Dec 22. pii: S0090-4295(17)31302.
    PubMed     Text format     Abstract available


  5. KAHOKEHR AA, Peterson AC
    Unmasking of Urinary-Pubic Symphysis Fistula (UPF) after Implantation of Artificial Urinary Sphincter in Prostate Cancer Survivors - User Beware. Url-D-17-02187.
    Urology. 2017 Dec 22. pii: S0090-4295(17)31301.
    PubMed     Text format     Abstract available


  6. ULLMAN D, Dorn D, Rais-Bahrami S, Gordetsky J, et al
    Clinical Utility and Biologic implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer.
    Urology. 2017 Dec 7. pii: S0090-4295(17)31219.
    PubMed     Text format     Abstract available


    November 2017
  7. WALLIS CJD, Satkunasivam R, Saskin R, Bansal S, et al
    Population-Based Analysis of Treatment Toxicity among Men with Castration-Resistant Prostate Cancer: a Phase IV Study.
    Urology. 2017 Nov 27. pii: S0090-4295(17)31221.
    PubMed     Text format     Abstract available



  8. Erratum to "Postoperative Adjuvant and Salvage Radiotherapy for Prostate Cancer: Impact on Freedom From Biochemical Relapse and Survival".
    Urology. 2017 Nov 20. pii: S0090-4295(17)31088.
    PubMed     Text format    


  9. BJURLIN MA, Rosenkrantz AB, Sarkar S, Lepor H, et al
    Prediction of Prostate Cancer Risk among Men Undergoing Combined MRI-Targeted and Systematic Biopsy Using Novel Pre-Biopsy Nomograms That Incorporate MRI Findings.
    Urology. 2017 Nov 16. pii: S0090-4295(17)31185.
    PubMed     Text format     Abstract available


  10. BARQAWI A, Huebner E, Krughoff K, O'Donnell CI, et al
    Prospective Outcome Analysis of the Safety and Efficacy of Partial and Complete Cryoablation in Organ-Confined Prostate Cancer.
    Urology. 2017 Nov 7. pii: S0090-4295(17)31163.
    PubMed     Text format     Abstract available


    October 2017
  11. ZHONG W, Smith B, Haghighi K, Mancuso P, et al
    Systematic Review of Decision Aids for the Management of Men with Localized Prostate Cancer.
    Urology. 2017 Oct 31. pii: S0090-4295(17)31154.
    PubMed     Text format     Abstract available


  12. SHARMA V, Yousefi K, Haddad Z, Buerki C, et al
    Gene Expression Correlates of Site-Specific Metastasis among Men with Lymph Node Positive Prostate Cancer Treated with Radical Prostatectomy: a Case Series.
    Urology. 2017 Oct 24. pii: S0090-4295(17)31099.
    PubMed     Text format     Abstract available


  13. KENIGSBERG AP, Llukani E, Deng FM, Melamed J, et al
    The Use of MRI to Predict Oncological Control among Candidates for Focal Ablation of Prostate Cancer.
    Urology. 2017 Oct 20. pii: S0090-4295(17)31097.
    PubMed     Text format     Abstract available


  14. NGUYEN A, O'Leary MP
    Re: Deebel et al.: Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges (Urology 2017, http://dx.doi.org/doi:10.1016/j.urology.2017.08.032).
    Urology. 2017 Oct 16. pii: S0090-4295(17)31076.
    PubMed     Text format    


    September 2017
  15. QURESHI ZP, Sartor O, Bennett CL
    Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer.
    Urology. 2017 Sep 20. pii: S0090-4295(17)30750.
    PubMed     Text format    


  16. SHORE N, Heidenreich A, Saad F
    Author Response on the Manuscript Titled "Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer" (#URL-D-17-01121).
    Urology. 2017 Sep 20. pii: S0090-4295(17)30751.
    PubMed     Text format    


  17. GOLOMBOS DM, Ayangbesan A, O'Malley P, Lewicki P, et al
    The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: a Prospective, Pilot Study.
    Urology. 2017 Sep 6. pii: S0090-4295(17)30957.
    PubMed     Text format     Abstract available


  18. WIENER S, Haddock P, Cusano J, Staff I, et al
    Incidence of Clinically Significant Prostate Cancer after a Diagnosis of Atypical Small Acinar Proliferation (ASAP), High Grade Prostatic Intraepithelial Neoplasia (HGPIN), or Benign Tissue.
    Urology. 2017 Sep 6. pii: S0090-4295(17)30958.
    PubMed     Text format     Abstract available


  19. DEEBEL NA, Morin JP, Autorino R, Vince R, et al
    Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges.
    Urology. 2017 Sep 4. pii: S0090-4295(17)30906.
    PubMed     Text format     Abstract available


    August 2017
  20. BOESEN L, Norgaard N, Logager V, Balslev I, et al
    Where Do TRUS- and MRI Guided Biopsies Miss Significant Prostate Cancer?
    Urology. 2017 Aug 30. pii: S0090-4295(17)30899.
    PubMed     Text format     Abstract available


  21. FRIEDL A, Stangl K, Bauer W, Kivaranovic D, et al
    Prostate-Specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction with the in-Bore 3-T MRI-Guided Transrectal Targeted Prostate Biopsy after Negative 12-Core Biopsy.
    Urology. 2017 Aug 24. pii: S0090-4295(17)30880.
    PubMed     Text format     Abstract available


  22. OROM H, Biddle C, Underwood W 3rd, Homish GG, et al
    Racial/Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-Specific Quality of Life.
    Urology. 2017 Aug 22. pii: S0090-4295(17)30866.
    PubMed     Text format     Abstract available


  23. BHINDI B, Carlson RE, Mason RJ, Schulte PJ, et al
    Long-Term Follow Up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-Confined Prostate Cancer with a Positive Surgical Margin.
    Urology. 2017 Aug 17. pii: S0090-4295(17)30853.
    PubMed     Text format     Abstract available


  24. AAS K, Axcrona K, Kvale R, Moller B, et al
    10-Year Mortality in Men with Non-Metastatic Prostate Cancer in Norway.
    Urology. 2017 Aug 17. pii: S0090-4295(17)30860.
    PubMed     Text format     Abstract available


  25. SHORE N, Heidenreich A, Saad F
    Predicting Response and Recognizing Resistance: Improving Outcomes in Patients with Castration-Resistant Prostate Cancer.
    Urology. 2017 Aug 7. pii: S0090-4295(17)30745.
    PubMed     Text format     Abstract available


  26. STRUSS WJ, Black PC
    Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-Sensitive Prostate Cancer.
    Urology. 2017 Aug 7. pii: S0090-4295(17)30779.
    PubMed     Text format    


    July 2017
  27. ZACHO HD, Gade M, Mortensen JC, Bertelsen H, et al
    Bone Scan Index is an Independent Predictor for Time to Castration-Resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: a Prospective Study.
    Urology. 2017 Jul 28. pii: S0090-4295(17)30759.
    PubMed     Text format     Abstract available


  28. ZACHO HD, Petersen LJ
    Reply by the authors to the Editorial on: Zacho HD, Gade M, Mortensen JC, Bertelsen H, Boldsen SK, Petersen LJ. Bone scan index is an independent predictor for time to castration resistant prostate cancer in newly diagnosed prostate cancer: A prospect
    Urology. 2017 Jul 26. pii: S0090-4295(17)30760.
    PubMed     Text format    


  29. HORIGUCHI A, Shinchi M, Nakamura A, Wada T, et al
    Pilot Study of Prostate Cancer Angiogenesis Imaging Using a Photoacoustic Imaging System.
    Urology. 2017 Jul 19. pii: S0090-4295(17)30733.
    PubMed     Text format     Abstract available


    June 2017
  30. SKOLARUS TA, Ragnoni JA, Garlinghouse C, Schafenacker A, et al
    Multilingual Self-Management Resources for Prostate Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health Department Partnership to Promote Survivorship Care.
    Urology. 2017 Jun 23. pii: S0090-4295(17)30637.
    PubMed     Text format     Abstract available


  31. GORIN MA, Pienta KJ, Pomper MG, Rowe SP, et al
    Prostate Cancer Local Recurrence Detected with Both 18F-Fluciclovine and PSMA-Targeted 18F-DCFPyL PET/CT.
    Urology. 2017 Jun 19. pii: S0090-4295(17)30635.
    PubMed     Text format     Abstract available


  32. MANNAS M, Chedgy E, Black PC
    You Pays Your Money, You Takes Your Choice: Functional Outcomes Following Curative Treatment for Clinically Localized Prostate Cancer.
    Urology. 2017 Jun 15. pii: S0090-4295(17)30625.
    PubMed     Text format    


  33. GRIVAS N, van der Roest R, Tillier C, Schouten D, et al
    Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging are Correlated with Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-Assisted Radical Prostatectomy for Prostate Cancer.
    Urology. 2017 Jun 7. pii: S0090-4295(17)30604.
    PubMed     Text format     Abstract available


    May 2017
  34. HEGDE JV, Veruttipong D, Said JW, Reiter RE, et al
    Prostate Cancer Antigen 3 (PCA3) Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-Free Survival in Clinically-Localized, Intermediate- and High-Risk Prostate Cancer.
    Urology. 2017 May 25. pii: S0090-4295(17)30565.
    PubMed     Text format     Abstract available


    April 2017
  35. DAVIS K, Bellini P, Hagerman C, Zinar R, et al
    Physicians' Perceptions of Factors Influencing the Treatment Decision-Making Process for Men with Low-Risk Prostate Cancer.
    Urology. 2017 Apr 25. pii: S0090-4295(17)30391.
    PubMed     Text format     Abstract available


  36. CANTIELLO F, Gangemi V, Cascini GL, Calabria F, et al
    Diagnostic Accuracy of 64Cu-PSMA PET/CT for Primary Lymph Node Staging of Intermediate to High Risk Prostate Cancer: Our Preliminary Experience.
    Urology. 2017 Apr 21. pii: S0090-4295(17)30385.
    PubMed     Text format     Abstract available


  37. XIA L, Zeh R, Mizelle J, Newton A, et al
    Near-Infrared Intraoperative Molecular Imaging Can Identify Metastatic Lymph Nodes in Prostate Cancer.
    Urology. 2017 Apr 21. pii: S0090-4295(17)30386.
    PubMed     Text format     Abstract available


  38. POELAERT F, Verbaeys C, Rappe B, Kimpe B, et al
    Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective LoMP Trial.
    Urology. 2017 Apr 20. pii: S0090-4295(17)30372.
    PubMed     Text format     Abstract available


  39. JUE JS, Barboza MP, Prakash NS, Venkatramani V, et al
    Re-Examining PSA Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy.
    Urology. 2017 Apr 18. pii: S0090-4295(17)30368.
    PubMed     Text format     Abstract available


  40. GUERRIOS-RIVERA L, Howard L, Frank J, De Hoedt A, et al
    Is BMI the Best Adiposity Measure for Prostate Cancer Risk? Results From a VA Biopsy Cohort.
    Urology. 2017 Apr 10. pii: S0090-4295(17)30347.
    PubMed     Text format     Abstract available


    March 2017
  41. JOHNSTON J, Struss WJ, Black PC
    Padeliporfin Vascular-Targeted Photodynamic Therapy Versus Active Surveillance in Men with Low-Risk Prostate Cancer (Clin1001 PCM301): an Open-Label, Phase 3, Randomised Control Trial.
    Urology. 2017 Mar 22. pii: S0090-4295(17)30274.
    PubMed     Text format    


  42. STRUSS WJ, Black PC
    Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
    Urology. 2017 Mar 22. pii: S0090-4295(17)30275.
    PubMed     Text format    


  43. PAKZAD R, Safiri S
    Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study; Methodological Issues.
    Urology. 2017 Mar 21. pii: S0090-4295(17)30272.
    PubMed     Text format    


  44. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
    Reply to Letter-to-the-Editor: Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study, Published in Urology. 2017 Jan;99:148-154.
    Urology. 2017 Mar 20. pii: S0090-4295(17)30269.
    PubMed     Text format    


  45. JOSHI A, Nicholson C, Rhee H, Gustafson S, et al
    Incidental Malignancies identified during staging for Prostate Cancer with 68Ga -PSMA HBED-CC PET imaging.
    Urology. 2017 Mar 20. pii: S0090-4295(17)30271.
    PubMed     Text format     Abstract available


  46. LU AJ, Syed JS, Nguyen KA, Nawaf CB, et al
    Negative Multi-Parametric MRI of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy.
    Urology. 2017 Mar 16. pii: S0090-4295(17)30247.
    PubMed     Text format     Abstract available


  47. PAKZAD R, Safiri S
    Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer: Methodological Issues.
    Urology. 2017 Mar 15. pii: S0090-4295(17)30244.
    PubMed     Text format    



  48. Erratum to "Predictors of Time to Metastasis in Castration-resistant Prostate Cancer".
    Urology. 2017 Mar 14. pii: S0090-4295(17)30113.
    PubMed     Text format    


  49. CRAWFORD ED, Petrylak DP, Shore N, Saad F, et al
    The Role of Therapeutic Layering in Optimizing Treatment for Patients with Castration-Resistant Prostate Cancer (RADAR II).
    Urology. 2017 Mar 13. pii: S0090-4295(16)31023.
    PubMed     Text format     Abstract available


    February 2017
  50. GORDETSKY J, Rais-Bahrami S, Epstein JI
    Pathological Findings in Multiparametric MRI/Ultrasound Fusion Guided Biopsy: Relation to Prostate Cancer Focal Therapy.
    Urology. 2017 Feb 23. pii: S0090-4295(17)30163.
    PubMed     Text format     Abstract available


  51. AUFFENBERG GB, Merdan S, Miller DC, Singh K, et al
    Evaluation of Prostate Cancer Risk Calculators for Shared-Decision Making Across Diverse Urology Practices in Michigan.
    Urology. 2017 Feb 22. pii: S0090-4295(17)30165.
    PubMed     Text format     Abstract available


  52. LANG MF, Tyson MD, Rudd Alvarez J, Koyama T, et al
    The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-Based Cohort.
    Urology. 2017 Feb 9. pii: S0090-4295(17)30123.
    PubMed     Text format     Abstract available


  53. GUNLUSOY B, Ceylan Y, Koskderlioglu A, Gedizlioglu M, et al
    Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer.
    Urology. 2017 Feb 7. pii: S0090-4295(17)30116.
    PubMed     Text format     Abstract available


  54. KIRK PS, Govani S, Borza T, Hollenbeck BK, et al
    Implications of Prostate Cancer Treatment in Men with Inflammatory Bowel Disease.
    Urology. 2017 Feb 2. pii: S0090-4295(17)30111.
    PubMed     Text format     Abstract available


    January 2017
  55. LIU JZ, Yin FY, Yan CY, Wang H, et al
    Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by Hsa-miR-125A-3P via Modulation of MTA1 Signaling.
    Urology. 2017 Jan 11. pii: S0090-4295(17)30013.
    PubMed     Text format     Abstract available


  56. FROEHNER M, Kuithan F, Zophel K, Heberling U, et al
    Prostate-specific Membrane Antigen-targeted Ligand Positron Emission Tomography/Computed Tomography and Immunohistochemical Findings in a Patient With Synchronous Metastatic Penile and Prostate Cancer.
    Urology. 2017 Jan 4. pii: S0090-4295(16)30923.
    PubMed     Text format     Abstract available


    December 2016
  57. FREITAS D, Andriole GL, Castro-Santamaria R, Freedland SJ, et al
    Extent of Baseline Prostate Atrophy is Associated with Lower Incidence of Low- and High-Grade Prostate Cancer on Repeat Biopsy.
    Urology. 2016 Dec 23. pii: S0090-4295(16)31014.
    PubMed     Text format     Abstract available


  58. KIM EH, Weaver JK, Shetty AS, Vetter JM, et al
    Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients with Estimated Risk of High Grade Prostate Cancer Less Than or Equal to 10.
    Urology. 2016 Dec 2. pii: S0090-4295(16)30917.
    PubMed     Text format     Abstract available


    November 2016
  59. ODERDA M, Cozzi G, Daniele L, Sapino A, et al
    CCP-Score Might Improve the Current Risk Assessment in Newly Diagnosed Prostate Cancer Patients.
    Urology. 2016 Nov 25. pii: S0090-4295(16)30914.
    PubMed     Text format     Abstract available


  60. O'SHAUGHNESSY MJ, McBride SM, Vargas HA, Touijer KA, et al
    A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early Stage Metastatic Prostate Cancer.
    Urology. 2016 Nov 22. pii: S0090-4295(16)30850.
    PubMed     Text format     Abstract available


  61. TURNER RM 2ND, Yecies TS, Yabes JG, Ristau BT, et al
    Biopsy Perineural Invasion in Prostate Cancer Patients Who are Candidates for Active Surveillance by Strict and Expanded Criteria.
    Urology. 2016 Nov 15. pii: S0090-4295(16)30826.
    PubMed     Text format     Abstract available


  62. GOMEZ-GOMEZ E, Carrasco-Valiente J, Blanca-Pedregosa A, Barco-Sanchez B, et al
    European Randomised Study for Screening of Prostate Cancer Risk Calculator: External Validation, Variability and Clinical Significance.
    Urology. 2016 Nov 10. pii: S0090-4295(16)30808.
    PubMed     Text format     Abstract available


    October 2016
  63. CUTRUZZULA P, Edwards D, Cahn D, Tong C, et al
    Metastatic Prostate Cancer Presenting as Lower Extremity Soft Tissue Mass: a Rare Case Presentation.
    Urology. 2016 Oct 17. pii: S0090-4295(16)30710.
    PubMed     Text format     Abstract available


  64. LEAPMAN M, Jazayeri SB, Katsigeorgis M, Hobbs A, et al
    Patient-Perceived Causes of Prostate Cancer: Result of an Internet Based Survey.
    Urology. 2016 Oct 17. pii: S0090-4295(16)30707.
    PubMed     Text format     Abstract available


  65. BOISSIER R, Udrescu C, Rebillard X, Terrier JE, et al
    Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
    Urology. 2016 Oct 7. pii: S0090-4295(16)30699.
    PubMed     Text format     Abstract available


  66. JONES TA, Natarajan S, Priester AM, Marks LS, et al
    Images in Clinical Urology - Focal Laser Ablation of Prostate Cancer.
    Urology. 2016 Oct 6. pii: S0090-4295(16)30700.
    PubMed     Text format     Abstract available


    September 2016
  67. MOSES KA, Orom H, Brasel A, Gaddy J, et al
    Racial/Ethnic Disparity in Treatment for Prostate Cancer: Does Cancer Severity Matter.
    Urology. 2016 Sep 22. pii: S0090-4295(16)30579.
    PubMed     Text format     Abstract available


  68. RUDICHUK L, Vogel KJ, Wang CH, Helfand BT, et al
    Urologists' Current Practices in Screening and Treating Men with a Family History of Prostate Cancer.
    Urology. 2016 Sep 16. pii: S0090-4295(16)30460.
    PubMed     Text format     Abstract available


  69. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
    Unexplained Bone Pain Is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: A Prospective Study.
    Urology. 2016 Sep 16. pii: S0090-4295(16)30625.
    PubMed     Text format     Abstract available


  70. SISSUNG TM, Venzon DJ, Figg WD
    Erratum to: Association of a CYP17 Polymorphism With Overall Survival in Caucasian Patients With Androgen-independent Prostate Cancer.
    Urology. 2016;95:225.
    PubMed     Text format    


  71. EGEVAD L, Samaratunga H, Srigley JR, Delahunt B, et al
    Consensus Guidelines for Reporting Prostate Cancer Gleason Grade.
    Urology. 2016 Sep 1. pii: S0090-4295(16)30402.
    PubMed     Text format    


  72. TAN WP, Lin C, Chen M, Deane L, et al
    Periprostatic Fat: A Risk Factor for Prostate Cancer?
    Urology. 2016 Sep 1. pii: S0090-4295(16)30551.
    PubMed     Text format     Abstract available


    August 2016
  73. GHABILI K, Tosoian JJ, Schaeffer EM, Pavlovich CP, et al
    The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies.
    Urology. 2016 Aug 31. pii: S0090-4295(16)30547.
    PubMed     Text format    


  74. LAVIEN G, Chery G, Zaid UB, Peterson AC, et al
    Pubic Bone Resection Provides Objective Pain Control in the Prostate Cancer Survivor with Pubic Bone Osteomyelitis with an Associated Urinary Tract to Pubic Symphysis Fistula.
    Urology. 2016 Aug 31. pii: S0090-4295(16)30550.
    PubMed     Text format     Abstract available


  75. FENSTERMAKER M, Mendhiratta N, Bjurlin MA, Meng X, et al
    Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.
    Urology. 2016 Aug 22. pii: S0090-4295(16)30535.
    PubMed     Text format     Abstract available


  76. KIM SP, Karnes RJ, Gross CP, Meropol NJ, et al
    Contemporary National Trends of Prostate Cancer Screening among Privately Insured Men in the United States.
    Urology. 2016 Aug 12. pii: S0090-4295(16)30512.
    PubMed     Text format     Abstract available


  77. WALLIS CJ, Mahar AL, Satkunasivam R, Herschorn S, et al
    Cardiovascular and Skeletal-Related Events Following Localised Prostate Cancer Treatment: Role of Surgery, Radiotherapy and Androgen-Deprivation.
    Urology. 2016 Aug 5. pii: S0090-4295(16)30494.
    PubMed     Text format     Abstract available


    July 2016
  78. HOFER MD, Morey AF, Sheth K, Tausch TJ, et al
    Low Serum Testosterone Level Predisposes to Artificial Urinary Sphincter Cuff Erosion.
    Urology. 2016 Jul 20. pii: S0090-4295(16)30422.
    PubMed     Text format     Abstract available


  79. CRAWFORD ED, Rosenberg MT, Partin AW, Cooperberg MR, et al
    An Approach Using PSA Levels of 1.5 ng/ml as the Cutoff for Prostate Cancer Screening in Primary Care.
    Urology. 2016 Jul 19. pii: S0090-4295(16)30383.
    PubMed     Text format    


  80. KLEIN EA, Smith JA, Zietman AL, Dasgupta P, et al
    Reply to the Letter to the Editor #16-01352: "Consensus Guidelines for Reporting Prostate Cancer Gleason Grade" by Hemamali Samaratunga.
    Urology. 2016 Jul 18. pii: S0090-4295(16)30401.
    PubMed     Text format    


  81. MORGIA G, Russo GI, Tubaro A, Bortolus R, et al
    Prevalence of Cardiovascular Disease and Osteoporosis during Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multi-Center Cross-Sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study.
    Urology. 2016 Jul 8. pii: S0090-4295(16)30315.
    PubMed     Text format     Abstract available


  82. ADEJORO O, Alishahi A, Konety B
    Association of Comorbidity, Age and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
    Urology. 2016 Jul 7. pii: S0090-4295(16)30303.
    PubMed     Text format     Abstract available


  83. LESTER-COLL NH, Park HS, Rutter CE, Corso CD, et al
    The Association between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-Risk Prostate Cancer.
    Urology. 2016 Jul 5. pii: S0090-4295(16)30371.
    PubMed     Text format     Abstract available


    June 2016
  84. ZHANG JH, Reichard CA, Plesec TP, Klein EA, et al
    A Case of Prostate Cancer in Lynch Syndrome.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30289.
    PubMed     Text format    


  85. MOREIRA DM, Howard LE, Sourbeer KN, Amarasekara HS, et al
    Predictors of Time to Metastasis in Castration-Resistant Prostate Cancer.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30294.
    PubMed     Text format     Abstract available


  86. WANG EH, Yu JB, Abouassally R, Meropol NJ, et al
    Disparities in Treatment of Patients with High-Risk Prostate Cancer: Results From A Population-Based Cohort.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30293.
    PubMed     Text format     Abstract available


  87. WU FJ, Sheu SY, Lin HC, Chung SD, et al
    Increased Fall Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer.
    Urology. 2016 Jun 15. pii: S0090-4295(16)30299.
    PubMed     Text format     Abstract available


  88. WALLIS CJ, Mahar AL, Cheung P, Herschorn S, et al
    Hospitalizations to Manage Complications of Modern Prostate Cancer Treatment in Older Men.
    Urology. 2016 Jun 8. pii: S0090-4295(16)30265.
    PubMed     Text format     Abstract available


  89. SHAH N, Ioffe V
    Re: The Memorial Sloan Kettering cancer center recommendations for prostate cancer screening. Andrew J Vickers et al. Urology 91: 12-18, 2016.
    Urology. 2016 Jun 1. pii: S0090-4295(16)30260.
    PubMed     Text format    


  90. VICKERS AJ, Eastham JA, Scardino PT, Lilja H, et al
    Reply to RE: The Memorial Sloan Kettering Cancer Center recommendations for prostate cancer screening.
    Urology. 2016 Jun 1. pii: S0090-4295(16)30257.
    PubMed     Text format    


    May 2016
  91. COHEN A, Lapin B, Wang CH, Helfand B, et al
    Variation in Testosterone Levels and Health Related Quality of Life in Men Diagnosed with Prostate Cancer on Active Surveillance.
    Urology. 2016 May 11. pii: S0090-4295(16)30152.
    PubMed     Text format     Abstract available


  92. SUN Y, Jia X, Hou L, Liu X, et al
    Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data.
    Urology. 2016 May 11. pii: S0090-4295(16)30149.
    PubMed     Text format     Abstract available


  93. HANSEN NL, Caglic I, Berman LH, Kastner C, et al
    Multiparametric Prostate MRI and Cognitively Targeted Transperineal Biopsy in Patients with Previous Abdominoperineal Resection and Suspicion of Prostate Cancer.
    Urology. 2016 May 4. pii: S0090-4295(16)30141.
    PubMed     Text format     Abstract available


  94. QUINTANA L, Ward A, Gerrin SJ, Genega EM, et al
    Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.
    Urology. 2016;91:143-9.
    PubMed     Text format     Abstract available


  95. KARATZAS AD, Zachos I, Mitrakas L, Dimitropoulos K, et al
    Generalized Lymphadenopathy of Prostate Adenocarcinoma Origin. A Case Series.
    Urology. 2016;91:e3-4.
    PubMed     Text format     Abstract available


  96. DASON S, Allard CB, Wright I, Shayegan B, et al
    Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique.
    Urology. 2016;91:129-35.
    PubMed     Text format     Abstract available


    April 2016
  97. IREMASHVILI V, Kava BR, Manoharan M, Parekh DJ, et al
    Is It Time to Revisit the Role of Prostate-Specific Antigen Kinetics in Active Surveillance for Prostate Cancer?
    Urology. 2016 Apr 26. pii: S0090-4295(16)30111.
    PubMed     Text format     Abstract available


  98. SERTKAYA Z
    Re: Fascelli M, Et Al. Combined Biparametric Prostate Magnetic Resonance Imaging and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy-Naive Patient Population.
    Urology. 2016 Apr 22. pii: S0090-4295(16)30106.
    PubMed     Text format    


  99. VAN ASSELDONK B, Black P, Elterman DS
    Chemical vs Surgical ADT in Metastatic Prostate Cancer: A Comparison of Side Effects.
    Urology. 2016 Apr 20. pii: S0090-4295(16)30059.
    PubMed     Text format    


  100. DASKIVICH TJ, Lai J, Dick AW, Setodji CM, et al
    Questioning the Ten-Year Life Expectancy Rule for High-Grade Prostate Cancer: Comparative Effectiveness of Aggressive Vs. Non-Aggressive Treatment of High-Grade Disease in Older Men with Differing Comorbid Disease Burdens.
    Urology. 2016 Apr 11. pii: S0090-4295(16)30064.
    PubMed     Text format     Abstract available


  101. KLEIN EA, Haddad Z, Yousefi K, Lam LL, et al
    Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.
    Urology. 2016;90:148-52.
    PubMed     Text format     Abstract available


  102. SCHWEN ZR, Tosoian JJ, Sokoll LJ, Mangold L, et al
    Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men.
    Urology. 2016;90:136-40.
    PubMed     Text format     Abstract available


  103. BENSON MC
    Editorial Comment.
    Urology. 2016;90:147.
    PubMed     Text format    


  104. KROUWEL EM, Elzevier HW
    Author Reply.
    Urology. 2016;90:25-6.
    PubMed     Text format    


  105. NIEDER AM
    Editorial Comment.
    Urology. 2016;90:25.
    PubMed     Text format    


    March 2016
  106. BHINDI B, Xie WY, Kulkarni GS, Hamilton RJ, et al
    Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy.
    Urology. 2016 Mar 22. pii: S0090-4295(16)00302.
    PubMed     Text format     Abstract available


  107. ZIETMAN A, Smith J, Klein E, Droller M, et al
    Consensus Guidelines for Reporting Prostate Cancer Gleason Grade.
    Urology. 2016 Mar 22. pii: S0090-4295(16)00280.
    PubMed     Text format    


  108. OSTBY-DEGLUM M, Axcrona K, Brennhovd B, Dahl AA, et al
    Ability to Reach Orgasm in Patients with Prostate Cancer Treated with Robot-assisted Laparoscopic Prostatectomy.
    Urology. 2016 Mar 10. pii: S0090-4295(16)00285.
    PubMed     Text format     Abstract available


  109. MANDEL P, Kriegmair MC, Veleva V, Salomon G, et al
    The Role of Pelvic Lymph Node Dissection during Radical Prostatectomy in Patients with Gleason Grade 6 Intermediate-Risk Prostate Cancer.
    Urology. 2016 Mar 8. pii: S0090-4295(16)00276.
    PubMed     Text format     Abstract available


  110. KISS B, Thoeny HC, Studer UE
    Current Status of Lymph Node Imaging in Bladder and Prostate Cancer.
    Urology. 2016 Mar 7. pii: S0090-4295(16)00182.
    PubMed     Text format     Abstract available


    February 2016
  111. SHORE ND, Crawford ED, Higano CS, Sartor O, et al
    Advancing Treatment Strategies in Metastatic Castration-resistant Prostate Cancer: The Urologists Role.
    Urology. 2016 Feb 25. pii: S0090-4295(15)01158.
    PubMed     Text format    


  112. DE SANTIS M, Saad F
    Practical Guidance on the Role of Corticosteroids in the Treatment of Metastatic Castration-Resistant Prostate Cancer.
    Urology. 2016 Feb 18. pii: S0090-4295(16)00146.
    PubMed     Text format     Abstract available


  113. PETRELLI F, Vavassori I, Cabiddu M, Coinu A, et al
    Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: a Systematic Review and Meta-Analysis.
    Urology. 2016 Feb 16. pii: S0090-4295(16)00127.
    PubMed     Text format     Abstract available


  114. KLAFF R, Rosell J, Varenhorst E, Sandblom G, et al
    The Long-Term Disease-Specific Mortality of Low-Risk Localized Prostate Cancer: a Prospective Population-Based Register Study Over Two Decades.
    Urology. 2016 Feb 12. pii: S0090-4295(16)00126.
    PubMed     Text format     Abstract available


  115. GAYLIS F, Cohen E, Calabrese R, Prime H, et al
    Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage and Improve?
    Urology. 2016 Feb 11. pii: S0090-4295(16)00112.
    PubMed     Text format     Abstract available


  116. VICKERS AJ, Eastham JA, Scardino PT, Lilja H, et al
    The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.
    Urology. 2016 Feb 2. pii: S0090-4295(16)00070.
    PubMed     Text format     Abstract available


  117. GEORGE AK, Rais-Bahrami S, Fascelli M, Turkbeyc B, et al
    Author Reply.
    Urology. 2016;88:133-4.
    PubMed     Text format    


  118. HOIMES CJ, Madabhushi A
    Editorial Comment.
    Urology. 2016;88:132-3.
    PubMed     Text format    


  119. BAKER D
    Editorial Comment.
    Urology. 2016;88:41-2.
    PubMed     Text format    


  120. SHIKANOV S
    Editorial Comment.
    Urology. 2016;88:41.
    PubMed     Text format    


  121. PAICH K, Wittmann D
    Author Reply.
    Urology. 2016;88:42.
    PubMed     Text format    


    January 2016
  122. KRYVENKO ON
    Re: PSA Mass Density - a Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity Related PSA Hemodilution: Author's Reply.
    Urology. 2016 Jan 25. pii: S0090-4295(16)00074.
    PubMed     Text format    


  123. PISHGAR F
    Re: PSA Mass Density - a Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity Related PSA Hemodilution.
    Urology. 2016 Jan 22. pii: S0090-4295(16)00073.
    PubMed     Text format    


  124. RAI BP, Baum R, Patel A, Hughes R, et al
    The Role PET with Gallium (Ga)-Labelled Prostate-Specific Membrane Antigen (PSMA) in the Management of Patient with Organ Confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and after Radical Prostatectomy.
    Urology. 2016 Jan 11. pii: S0090-4295(16)00011.
    PubMed     Text format     Abstract available


  125. KRYVENKO ON, Diaz M, Matoso A, Kates M, et al
    PSA Mass Density - A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity: Related PSA Hemodilution.
    Urology. 2016 Jan 7. pii: S0090-4295(16)00002.
    PubMed     Text format     Abstract available


  126. KROUWEL EM, Palacios LA, Putter H, Pelger RC, et al
    Omissions in Urology Residency Training Regarding Sexual Dysfunction Subsequent to Prostate Cancer Treatment: Identifying a Need.
    Urology. 2016 Jan 6. pii: S0090-4295(15)01194.
    PubMed     Text format     Abstract available


  127. HENSEL J, Thalmann GN
    Biology of Bone Metastases in Prostate Cancer.
    Urology. 2016 Jan 5. pii: S0090-4295(15)01193.
    PubMed     Text format     Abstract available


  128. NGUYEN PL
    Editorial comment.
    Urology. 2016;87:152.
    PubMed     Text format    


  129. MOUL JW
    Editorial comment.
    Urology. 2016;87:131-2.
    PubMed     Text format    


  130. REEVES F, Everaerts W, Murphy DG, Kiers L, et al
    Stimulation of the Neurovascular Bundle Results in Rhabdosphincter Contraction in a Proportion of Men Undergoing Radical Prostatectomy.
    Urology. 2016;87:133-9.
    PubMed     Text format     Abstract available


    December 2015
  131. CHEDGY EC, Black PC
    "Moving Beyond the Androgen Receptor in Advanced Prostate Cancer".
    Urology. 2015 Dec 23. pii: S0090-4295(15)01107.
    PubMed     Text format    


  132. BRAND TC, Zhang N, Crager MR, Maddala T, et al
    Patient-Specific Meta-Analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.
    Urology. 2015 Dec 23. pii: S0090-4295(15)01142.
    PubMed     Text format     Abstract available


  133. FASCELLI M, Rais-Bahrami S, Sankineni S, Brown AM, et al
    Combined Biparametric Prostate MRI and Prostate Specific Antigen in the Detection of Prostate Cancer: a Validation Study in a Biopsy Naive Patient Population.
    Urology. 2015 Dec 8. pii: S0090-4295(15)01091.
    PubMed     Text format     Abstract available


    November 2015
  134. JAROW JP, Ahmed HU, Choyke PL, Taneja SS, et al
    Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop.
    Urology. 2015 Nov 24. pii: S0090-4295(15)01066.
    PubMed     Text format     Abstract available


    October 2015
  135. LEPOR H
    Reply: To PMID 26163812.
    Urology. 2015;86:788-9.
    PubMed     Text format    


  136. MOUL JW
    Editorial Comment.
    Urology. 2015;86:788.
    PubMed     Text format    


  137. JOHNSON D
    Editorial Comment.
    Urology. 2015;86:823.
    PubMed     Text format    


  138. PACKIAM VT, Patel SG, Pariser JJ, Richards KA, et al
    Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate.
    Urology. 2015;86:777-82.
    PubMed     Text format     Abstract available


  139. MURPHY G, Haddock P, Doak H, Jackson M, et al
    Urinary Bother as a Predictor of Postsurgical Changes in Urinary Function After Robotic Radical Prostatectomy.
    Urology. 2015;86:817-23.
    PubMed     Text format     Abstract available


    September 2015
  140. NASSIRI N, Natarajan S, Margolis DJ, Marks LS, et al
    Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology.
    Urology. 2015;86:432-8.
    PubMed     Text format     Abstract available


  141. MARKOWSKI MC, Eisenberger MA, Zahurak M, Epstein JI, et al
    Sarcomatoid Carcinoma of the Prostate: Retrospective Review of a Case Series From the Johns Hopkins Hospital.
    Urology. 2015;86:539-43.
    PubMed     Text format     Abstract available


  142. LOEB S
    Editorial Comment.
    Urology. 2015;86:504-5.
    PubMed     Text format    


  143. BRAWLEY OW
    Editorial Comment.
    Urology. 2015;86:504.
    PubMed     Text format    


  144. WALLNER LP, Loo RK, Jacobsen SJ
    Reply: To PMID 26123517.
    Urology. 2015;86:505.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: